183 related articles for article (PubMed ID: 38473753)
1. Fibroblast Growth Factor Receptor Inhibitors Decrease Proliferation of Melanoma Cell Lines and Their Activity Is Modulated by Vitamin D.
Piotrowska A; Nowak JI; Wierzbicka JM; Domżalski P; Górska-Arcisz M; Sądej R; Popiel D; Wieczorek M; Żmijewski MA
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473753
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D and its low calcemic analogs modulate the anticancer properties of cisplatin and dacarbazine in the human melanoma A375 cell line.
Piotrowska A; Wierzbicka J; Rybarczyk A; Tuckey RC; Slominski AT; Żmijewski MA
Int J Oncol; 2019 Apr; 54(4):1481-1495. PubMed ID: 30968156
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative activity of side-chain truncated vitamin D analogs (PRI-1203 and PRI-1204) against human malignant melanoma cell lines.
Piotrowska A; Wierzbicka J; Kwiatkowska K; Chodyński M; Kutner A; Żmijewski MA
Eur J Pharmacol; 2020 Aug; 881():173170. PubMed ID: 32445704
[TBL] [Abstract][Full Text] [Related]
4. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.
Reichrath J; Rech M; Moeini M; Meese E; Tilgen W; Seifert M
Cancer Biol Ther; 2007 Jan; 6(1):48-55. PubMed ID: 17172823
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative Activity of Non-Calcemic Vitamin D Analogs on Human Melanoma Lines in Relation to VDR and PDIA3 Receptors.
Wasiewicz T; Piotrowska A; Wierzbicka J; Slominski AT; Zmijewski MA
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200275
[TBL] [Abstract][Full Text] [Related]
7. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D Modulates the Response of Patient-Derived Metastatic Melanoma Cells to Anticancer Drugs.
Piotrowska A; Zaucha R; Król O; Żmijewski MA
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175742
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D Enhances Anticancer Properties of Cediranib, a VEGFR Inhibitor, by Modulation of VEGFR2 Expression in Melanoma Cells.
Piotrowska A; Beserra FP; Wierzbicka JM; Nowak JI; Żmijewski MA
Front Oncol; 2021; 11():763895. PubMed ID: 35004285
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative Activity of Double Point Modified Analogs of 1,25-Dihydroxyvitamin D₂ Against Human Malignant Melanoma Cell Lines.
Piotrowska A; Wierzbicka J; Nadkarni S; Brown G; Kutner A; Żmijewski MA
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26760999
[TBL] [Abstract][Full Text] [Related]
12. Preclinical characterization of CPL304110 as a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3 for gastric, bladder, and squamous cell lung cancer.
Popiel D; Stańczak A; Skupińska M; Mikołajczyk A; Stańczak P; Mituła F; Hucz-Kalitowska J; Jastrzębska K; Smuga D; Dominowski J; Delis M; Mulewski K; Pietruś W; Zdżalik-Bielecka D; Dzwonek K; Lamparska-Przybysz M; Yamani A; Olejkowska P; Piórkowska N; Dubiel K; Wieczorek M; Pieczykolan J
Front Oncol; 2023; 13():1293728. PubMed ID: 38282676
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of vitamin D analogs on hamster and mouse melanoma cell lines in relation to melanin pigmentation.
Wasiewicz T; Szyszka P; Cichorek M; Janjetovic Z; Tuckey RC; Slominski AT; Zmijewski MA
Int J Mol Sci; 2015 Mar; 16(4):6645-67. PubMed ID: 25811927
[TBL] [Abstract][Full Text] [Related]
14. Vitamin K2 enhances the tumor suppressive effects of 1,25(OH)
Narvaez CJ; Bak MJ; Salman N; Welsh J
J Steroid Biochem Mol Biol; 2023 Jul; 231():106307. PubMed ID: 37030416
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D in thyroid tumorigenesis and development.
Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
[TBL] [Abstract][Full Text] [Related]
17. Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance.
Chell V; Balmanno K; Little AS; Wilson M; Andrews S; Blockley L; Hampson M; Gavine PR; Cook SJ
Oncogene; 2013 Jun; 32(25):3059-70. PubMed ID: 22869148
[TBL] [Abstract][Full Text] [Related]
18. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
[TBL] [Abstract][Full Text] [Related]
19. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
20. 1α,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells.
Sundaram K; Sambandam Y; Tsuruga E; Wagner CL; Reddy SV
Horm Cancer; 2014 Apr; 5(2):90-7. PubMed ID: 24497297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]